Evidence map›Paper›PMID 41481098›Full record

ArticleScience progress

The moderation effect of remnant cholesterol for linking cerebrospinal fluid interleukin 10 to blood pressure.

Xiaoyu Yang, Lidong Su, Jiubo Fan, Yuanyuan Chen, Zhuqing Yang, Yimin Kang, Xingguang Luo, Xiaoli Han, Yanlong Liu, Fan Wang

Abstract read
In one paragraph

Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xiaoyu YangDepartment of Anesthesiology, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
Lidong SuDepartment of Anesthesiology, the Third Affiliated Hospital of Inner Mongolia Medical University, BaoGang Hospital, Baotou, China.
Jiubo FanXiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.
Yuanyuan ChenBeijing Hui-Long-Guan Hospital, Peking University, Beijing, China.
Zhuqing YangBeijing Hui-Long-Guan Hospital, Peking University, Beijing, China.
Yimin KangMedical Neurobiology Lab, Inner Mongolia Medical University, Huhhot, China.
Xingguang LuoDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Xiaoli HanClinical Nutrition Department, Friendship Hospital, Urumqi, China.
Yanlong LiuSchool of Mental Health, Wenzhou Medical University, Wenzhou, China.
Fan WangBeijing Hui-Long-Guan Hospital, Peking University, Beijing, China.ORCID 0000-0002-7048-8166

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundInflammation is a key component in the pathophysiology of hypertension, in which proinflammatory cytokines interleukin (IL) 1β and IL6 and anti-inflammatory cytokines IL4 and IL10 are involved. Elevated remnant cholesterol (RC) level has emerged as an independent risk factor of incident hypertension, surpassing conventional risk factors based on its strength. Additionally, it has a higher penetration into the arterial wall than conventional lipids and induces arterial wall and systemic inflammations.ObjectiveThis study aimed to investigate the association between cerebrospinal fluid (CSF) ILs, blood pressure (BP), and RC and examine the moderation effects of RC on the relationship between ILs and BP.MethodsThis cross-sectional study included participants (mean age: 31.76 ± 10.22 years) who were divided into RC < 0.8 mmol/L (n = 81) and RC ≥ 0.8 mmol/L (n = 104) groups. BP was measured on the morning before CSF collection, and CSF IL levels were analyzed using ELISA. The linear regression models were constructed to estimate the moderation of RC on the relationship between ILs and BP.ResultsRC may play a moderation role in the relationship between IL10 and BP (R

Indexed as

Blood PressureCholesterolHypertensionInterleukin-10AdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedRisk FactorsCholesterolIL10 protein, humanInterleukin-10blood pressureCerebrospinal fluidinterleukin 10moderationremnant cholesterol

Identifiers

PMID41481098
PMCPMC12759153

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.